Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Top institutional share ownership of Zomedica Pharmaceuticals Corp.

Name Shares Shares % change Value Value % change
Vanguard Group Inc 44,076,354 8.5% $9,702 -29.1%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 29,069,093 15.8% $6,398 -24.4%
VEXMX - Vanguard Extended Market Index Fund Investor Shares 13,205,251 0.0% $2,906 -34.7%
BlackRock Inc. 11,353,498 -15.4% $2,499 -44.8%
Cambridge Investment Research Advisors, Inc. 11,172,160 0.1% $2,459 -34.7%
Geode Capital Management, Llc 8,927,712 9.3% $1,964 -28.7%
FSMAX - Fidelity Extended Market Index Fund 5,216,895 0.0% $1,220 -35.0%
State Street Corp 3,338,381 -82.2% $735 -88.4%
PROSHARES TRUST - ProShares Pet Care ETF 2,877,272 -27.8% $673 -53.2%
Renaissance Technologies Llc 2,507,500 $552

Top institutional buyers of Zomedica Pharmaceuticals Corp.

Name Shares % change Value % change Shares Value
Jane Street Group, Llc 413.9% 235.2% 1,082,261 $238
Millennium Management Llc 240.9% 123.6% 557,672 $123
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 15.8% -24.4% 29,069,093 $6,398
ITOT - iShares Core S&P Total U.S. Stock Market ETF 9.4% -28.5% 1,105,973 $243
Geode Capital Management, Llc 9.3% -28.7% 8,927,712 $1,964
Vanguard Group Inc 8.5% -29.1% 44,076,354 $9,702
NUSC - Nuveen ESG Small-Cap ETF 5.3% -16.4% 1,158,976 $286
Gsa Capital Partners Llp 3.6% -32.4% 1,272,480 $280
Cambridge Investment Research Advisors, Inc. 0.1% -34.7% 11,172,160 $2,459

Top institutional sellers of Zomedica Pharmaceuticals Corp.

Name Shares % change Value % change Shares Value
State Street Corp -82.2% -88.4% 3,338,381 $735
PROSHARES TRUST - ProShares Pet Care ETF -27.8% -53.2% 2,877,272 $673
Northern Trust Corp -23.8% -50.3% 1,679,249 $369
BlackRock Inc. -15.4% -44.8% 11,353,498 $2,499
Morgan Stanley -8.2% -39.8% 561,577 $124
Bank of New York Mellon Corp -0.2% -34.7% 581,518 $128
VEXMX - Vanguard Extended Market Index Fund Investor Shares 0.0% -34.7% 13,205,251 $2,906

Information provided by Fintel.io